Provided by Tiger Fintech (Singapore) Pte. Ltd.

AzurRx Biopharma Inc.

3.45
+0.0000
Volume:- -
Turnover:2.20M
Market Cap:34.33M
PE:-0.22
High:3.45
Open:3.45
Low:3.45
Close:3.45
Loading ...

AzurRx BioPharma Closes $15.2 Million Private Placement and $6.9 Million Convertible Note Exchange

GlobeNewswire
·
20 Jul 2020

AZRX: Next Up: OPTION 2

Zacks Small Cap Research
·
01 Jun 2020

Here is What Hedge Funds Think About AzurRx BioPharma, Inc. (AZRX)

Insider Monkey
·
30 May 2020

AzurRx BioPharma Announces Entry into Packaging, Labeling and Distribution Agreement with Creapharm Clinical Supplies for MS1819 Clinical Trial Drug Product

GlobeNewswire
·
07 May 2020

AzurRx BioPharma Receives Approximately $721,000 for its 2019 CIR (French Research Tax Credit)

GlobeNewswire
·
05 May 2020

What Kind Of Share Price Volatility Should You Expect For AzurRx BioPharma, Inc. (NASDAQ:AZRX)?

Simply Wall St.
·
04 May 2020

AzurRx BioPharma Receives Approval to Conduct its Phase 2 OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis Therapeutics Development Network Sites

GlobeNewswire
·
29 Apr 2020

Azurrx Biopharma - CEO Issued Letter To Shareholders

T-Reuters
·
21 Apr 2020

AzurRx BioPharma Issues Letter to Shareholders

GlobeNewswire
·
21 Apr 2020

Argus Research Initiates Equity Research Report Coverage on AzurRx BioPharma, Inc. (NasdaqCM: AZRX)

GlobeNewswire
·
20 Apr 2020

AzurRx Announces Manufacturing Agreement with Delpharm for MS1819 Clinical Drug Product

GlobeNewswire
·
17 Apr 2020

AzurRx BioPharma to Present at the Planet MicroCap Showcase Virtual Investor Conference 2020

ACCESSWIRE
·
15 Apr 2020

AzurRx Appoints Gregory Oakes to its Board of Directors

GlobeNewswire
·
09 Apr 2020

AZRX: Tax Credits Augment Cash Flow

Zacks Small Cap Research
·
09 Apr 2020

AzurRx BioPharma Receives $642,000 for its 2017 CIR (French Research Tax Credit)

GlobeNewswire
·
02 Apr 2020

AzurRx BioPharma to Present at the New York City based Investor Summit on March 25th-26th

ACCESSWIRE
·
18 Mar 2020

AzurRx BioPharma Receives $1.13 million in 2018 CIR (French Research Tax Credit)

GlobeNewswire
·
02 Mar 2020

AzurRx BioPharma Announces Presentation of Phase II MS1819 Data in Cystic Fibrosis at the 2020 Digestive Disease Week Conference

GlobeNewswire
·
18 Feb 2020

Azurrx Biopharma Inc Files Prospectus Relates To Offer, Sale Of Up To 11.6 Million Shares Of Common Stock By Certain Of Shareholders

T-Reuters
·
08 Feb 2020